The COVID-19 Pandemic Impact on Cardio-Oncology: Results From the COVID-19 International Collaborative Network Survey.
Diego Sadler(University of Chicago), Susan Dent(Government of the United States of America), Sebastian Szmit, Arjun K. Ghosh(Royal London Hospital), Lauren A. Baldassarre(Yale University), Roohi Ismail‐Khan(Moffitt Cancer Center), Monika Leja(University of Michigan), Vlad G. Zaha(Southwestern Medical Center), Jorge A. Lax(University of Minnesota), Luis M. Raez(Florida International University), Zeina Nahleh(Cleveland Clinic Florida), Sherry‐Ann Brown(Medical College of Wisconsin), Anne Blaes(University of Minnesota), Husam Abdel‐Qadir(University Health Network), Andrés J. Daniele(Universidad de Buenos Aires), J. Raikhelkar(Columbia University Irving Medical Center), Leah Elson(Yale University), Carolina Maria Pinto Domingues Carvalho Silva(Universidade de São Paulo), Brenton Bauer(Torrance Memorial Medical Center), Eric H. Yang(University of California, Los Angeles), Jeanne M. DeCara(University of Chicago), Anita Arnold(St Bartholomew's Hospital), Daniel Sierra Lara(Franciscan Health Indianapolis), Franck Thuny, Kerry Skurka(Franciscan Health Indianapolis), Nausheen Akhter, Joerg Herrmann(Mayo Clinic), Rupal O’Quinn(Aix-Marseille Université), Tochukwu Okwuosa, Rohit Moudgil(Cleveland Clinic), Vijay Rao(Franciscan Health Indianapolis), Lavanya Kondapalli(Moffitt Cancer Center)
Cited by 3
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal - Cardiovascular Imaging|2022|486
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416